A novel N-terminal cyclic dynorphin a analogue cycloN,5[Trp3,Trp4,Glu5] dynorphin A-(1-11)NH2 that lacks the basic N-terminus

被引：29

作者：

Vig, BS

Murray, TF

Aldrich, JV ^{[1
]}

机构：

[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA

[2] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA

[3] Univ Kansas, Sch Pharm, Dept Med Chem, Lawrence, KS 66045 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2003年 / 46卷 / 08期

关键词：

D O I：

10.1021/jm0256023

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel N-terminal-to-side chain cyclic dynorphin A analogue lacking the basic N-terminus was designed based on Ac[LyS(2),Trp(3),Trp(4),D-Ala(8)]dynorphin A-(1-11)NH2 (Wan et al. J. Med. Chem. 1999, 42, 3011-3013). cyclo(N-5)-[Trp(3),Trp(4),Glu(5)]dynorphin A-(1-11)NH2 showed similar kappa opioid receptor affinity (K-i = 27 nM) and selectivity (K-i ratio (kappa/mu/delta) = 1/12/330) to the linear peptide and antagonized dynorphin A-(1 - 13)NH2 at kappa opioid receptors. This is the first opioid peptide cyclized through the N-terminus that retains high opioid receptor affinity.

引用

收藏

页码：1279 / 1282

页数：4

相关论文

共 52 条

[1]

Aldrich JV, 2000, PEPTIDES FOR THE NEW MILLENNIUM, P616

[2]

ALDRICH JV, 2003, IN PRESS BURGERS MED

[3] SYNTHESIS AND OPIOID ACTIVITY OF CONFORMATIONALLY CONSTRAINED DYNORPHIN-A ANALOGS .1. CONFORMATIONAL CONSTRAINT IN THE MESSAGE SEQUENCE [J].

ARTTAMANGKUL, S ;

MURRAY, TF ;

DELANDER, GE ;

ALDRICH, JV .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (13) :2410-2417

[4] Synthesis and opioid activity of conformationally constrained dynorphin A analogues .2. Conformational constraint in the ''Address'' sequence [J].

Arttamangkul, S ;

Ishmael, JE ;

Murray, TF ;

Grandy, DK ;

DeLander, GE ;

Kieffer, BL ;

Aldrich, JV .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (08) :1211-1218

[5] kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression [J].

Chao, CC ;

Gekker, G ;

Hu, SX ;

Sheng, WS ;

Shark, KB ;

Bu, DF ;

Archer, S ;

Bidlack, JM ;

Peterson, PK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :8051-8056

[6] SPECIFIC RECEPTOR FOR THE OPIOID PEPTIDE DYNORPHIN - STRUCTURE-ACTIVITY-RELATIONSHIPS [J].

CHAVKIN, C ;

GOLDSTEIN, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (10) :6543-6547

[7] N-TERMINAL ALKYLATED DERIVATIVES OF [D-PRO10]DYNORPHIN A-(1-11) ARE HIGHLY SELECTIVE FOR K-OPIOID RECEPTORS [J].

CHOI, H ;

MURRAY, TF ;

DELANDER, GE ;

CALDWELL, V ;

ALDRICH, JV .

JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (24) :4638-4639

[8] Synthesis and opioid activity of [D-Pro(10)]dynorphin A-(1-11) analogues with N-terminal alkyl substitution [J].

Choi, H ;

Murray, TF ;

DeLander, GE ;

Schmidt, WK ;

Aldrich, JV .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (17) :2733-2739

[9]

Dhawan BN, 1996, PHARMACOL REV, V48, P567

[10] N,N-DIALLYL-TYROSYL SUBSTITUTION CONFERS ANTAGONIST PROPERTIES ON THE KAPPA-SELECTIVE OPIOID PEPTIDE [D-PRO10]DYNORPHIN A(1-11) [J].

GAIRIN, JE ;

MAZARGUIL, H ;

ALVINERIE, P ;

BOTANCH, C ;

CROS, J ;

MEUNIER, JC .

BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (04) :1023-1030

← 1 2 3 4 5 6 →